Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lisata Therapeutics, Inc.
Age
21–81
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who have received treatment with Auto-CD34+ cells or with placebo and who have completed the final study visit (Month 12) of the core therapeutic study 24779
Subjects who are willing to comply with the specified follow-up evaluations in this study and to provide written informed consent to participate in this study
